A global perspective on vasoactive agents in shock

Intensive Care Medicine

Volumn 44, Issue 6, 2018, Pages 833-846

  Annane, Djillali ^a   Ouanes Besbes, Lamia ^b   de Backer, Daniel ^c   Du, Bin ^d   Gordon, Anthony C ^e   Hernández, Glenn ^f   Olsen, Keith M ^g   Osborn, Tiffany M ^h   Peake, Sandra ^i,j   Russell, James A ^k   Cavazzoni, Sergio Zanotti ^l  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^h BARNES JEWISH HOSPITAL   (United States)

ⁱ UNIVERSITY OF ADELAIDE   (Australia)

^j MONASH UNIVERSITY   (Australia)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^l Sound Critical Care   (United States)

more..

Author keywords

Adrenergic agonists; Cardiovascular system; Clinical trials; Practice guidelines; Shock

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM SENSITIZER; CATECHOLAMINE; HORMONE; INOTROPIC AGENT; VASOACTIVE AGENT; VASOPRESSIN; VASOPRESSIN DERIVATIVE; CARDIOTONIC AGENT; DOBUTAMINE; NORADRENALIN; VASOCONSTRICTOR AGENT;

CARDIOVASCULAR EFFECT; CIRCULATION; HUMAN; IMMUNE DEFICIENCY; LUNG CIRCULATION; METABOLISM; MICROCIRCULATION; REVIEW; SEPTIC SHOCK; SHOCK; SURVIVAL; SYSTEMIC CIRCULATION; WEANING; INTENSIVE CARE UNIT;

CARDIOTONIC AGENTS; DOBUTAMINE; HUMANS; INTENSIVE CARE UNITS; NOREPINEPHRINE; SHOCK; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 85047978819     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-018-5242-5     Document Type: Review

References (117)

1. Goodman and Gilman’s (2011) Pharmacological Basis of Therapeutics Twelfth (ed). New York
2. Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for the management of sepsis and septic shock: 2016. Intensive Care Med 43:304–377
3. Aguilera G, Rabadan-Diehl C (2000) Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul Pept 96(1–2):23–29
4. Yamamoto K, Ikeda U, Okada K et al (1997) Arginine vasopressin increases nitric oxide synthesis in cytokine-stimulated rat cardiac myocytes. Hypertension 30(5):1112–1120
5. Rudichenko VM, Beierwaltes WH (1995) Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J Vasc Res 32(2):100–105
6. Landry DW, Levin HR, Gallant EM et al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95(5):1122–1125
7. Landry DW, Levin HR, Gallant EM et al (1997) Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25(8):1279–1282
8. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA (2001) The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 27(8):1416–1421
9. Malay MB, Ashton RC Jr, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47(4):699–703
10. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96(3):576–582
11. Siami S, Polito A, Porcher R et al (2013) Thirst perception and osmoregulation of vasopressin secretion are altered during recovery from septic shock. PLoS One 8(11):e80190
12. Boucheix OB, Milano SP, Henriksson M, Reinheimer TM (2013) Selepressin, a new V1A receptor agonist: hemodynamic comparison to vasopressin in dogs. Shock 39(6):533–538
13. Asfar P, Russell JA, Tuckermann J, Radermacher P (2016) Selepressin in septic shock: a step toward decatecholaminization? Crit Care Med 44(1):234–236
14. Russell JA, Vincent JL, Kjolbye AL et al (2017) Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients. Crit Care 21(1):213
15. He X, Su F, Taccone FS, Laporte R et al (2016) A selective V(1A) receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock. Crit Care Med 44(1):23–31
16. Maybauer MO, Maybauer DM, Enkhbaatar P et al (2014) The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*. Crit Care Med 42(7):e525–e533
17. Farmakis D, Alvarez J, Gal TB et al (2016) Levosimendan beyond inotropy and acute heart failure: evidence of pleiotropic effects on the heart and other organs: an expert panel position paper. Int J Cardiol 222:303–312
18. Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365(9453):63–78
19. Boldt J, Menges T, Kuhn D, Diridis C, Hempelmann G (1995) Alterations in circulating vasoactive substances in the critically ill–a comparison between survivors and non-survivors. Intensive Care Med 21(3):218–225
20. de Montmollin E, Aboab J, Mansart A, Annane D (2009) Bench-to-bedside review: beta-adrenergic modulation in sepsis. Crit Care 13(5):230
21. Reynolds RD, Gorczynski RJ, Quon CY (1986) Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol 26(suppl A):A3–A14
22. Atarashi H, Kuruma A, Yashima M et al (2000) Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 68(2):143–150
23. Page IH, Helmer OM (1940) A crystalline pressor substance (Angiotonin) resulting form the reaction between renin and renin-activator. J Exp Med 71(1):29–42
24. Rajagopalan S, Kurz S, Münzel T et al (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97(8):1916–1923
25. Khanna A, English SW, Wang XS et al (2017) Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 377:419–430
26. Vincent JL, De Backer D (2013) Circulatory shock. N Engl J Med 369(18):1726–1734
27. Perez P, Kimmoun A, Blime V, Levy B (2014) Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation. Shock 41(4):269–274
28. Maas JJ, Pinsky MR, de Wilde RB, de Jonge E, Jansen JR (2013) Cardiac output response to norepinephrine in postoperative cardiac surgery patients: interpretation with venous return and cardiac function curves. Crit Care Med 41(1):143–150
29. Levy B, Perez P, Perny J, Thivilier C, Gerard A (2011) Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 39(3):450–455
30. Guinot PG, Longrois D, Kamel S, Lorne E, Dupont H (2018) Ventriculo-arterial coupling analysis predicts the hemodynamic response to norepinephrine in hypotensive postoperative patients: a prospective observational study. Crit Care Med 46(1):e17–e25
31. Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F (2008) Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 36(6):1701–1706
32. Sun D, Huang A, Mital S et al (2002) Norepinephrine elicits beta2-receptor-mediated dilation of isolated human coronary arterioles. Circulation 106(5):550–555
33. Annane D, Vignon P, Renault A et al (2007) Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 370(9588):676–684
34. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J, CAT Study investigators (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34(12):2226–2234
35. Marik PE, Mohedin M (1994) The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 272(17):1354–1357
36. van Diepen S, Katz JN, Albert NM et al (2017) Contemporary management of cardiogenic shock: a scientific statement from the American heart association. Circulation 136(16):e232–e268
37. Mon W, Stewart A, Fernando R et al (2017) Cardiac output changes with phenylephrine and ephedrine infusions during spinal anesthesia for cesarean section: a randomized, double-blind trial. J Clin Anesth 37:43–48
38. Wasilewski MA, Grisanti LA, Song J et al (2016) Vasopressin type 1A receptor deletion enhances cardiac contractility, β-adrenergic receptor sensitivity and acute cardiac injury-induced dysfunction. Clin Sci 130(22):2017–2027. 10.1042/CS20160363
39. Bouferrache K, Amiel JB, Chimot L et al (2012) Initial resuscitation guided by the surviving sepsis campaign recommendations and early echocardiographic assessment of hemodynamics in intensive care unit septic patients: a pilot study. Crit Care Med 40(10):2821–2827
40. Schumann J, Henrich EC, Strobl H et al. (2018) Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database of Systematic Reviews. Issue 1, Art. No.: CD009669
41. Morelli A, Ertmer C, Westphal M et al (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310(16):1683–1691
42. Aviado DM Jr, Schmidt CF (1957) Effects of sympathomimetic drugs on pulmonary circulation: with special reference to a new pulmonary vasodilator. J Pharmacol Exp Ther 120(4):512–527
43. Monnet X, Jabot J, Maizel J, Richard C, Teboul JL (2011) Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Crit Care Med 39(4):689–694
44. Persichini R, Silva S, Teboul JL et al (2012) Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med 40(12):3146–3153
45. Hajjar LA, Vincent JL, Barbosa Gomes Galas FR et al (2017) Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the vancs randomized controlled trial. Anesthesiology 126(1):85–93
46. James A, Amour J (2018) Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: a discussion of the level of evidence. Anesthesiology 128(1):228
47. Cheng Y, Pan T, Ge M, et al. (2018) Evaluation of vasopressin for vasoplegic shock in patients with preoperative left ventricular dysfunction after cardiac surgery: a propensity-score analysis. Shock. Feb 7. 10.1097/shk.0000000000001114
48. Lewis RJ, Angus DC, Laterre PF et al (2018) Rationale and design of an adaptive phase 2b/3 clinical trial of selepressin for adults in septic shock, Selepressin evaluation program for sepsis-induced shock-adaptive clinical trial. Ann Am Thorac Soc 15(2):250–257
49. Gordon AC, Perkins GD, Singer M et al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 375(17):1638–1648
50. 2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 157:1219–1225
51. Hernandez G, Bruhn A, Luengo C et al (2013) Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. Intensive Care Med 39:1435–1443
52. De Backer D, Creteur J, Silva E, Vincent JL (2003) Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31:1659–1667
53. van Haren FM, Rozendaal FW, van der Hoeven JG (2003) The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124:2256–2260
54. Georger JF, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul JL (2010) Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med 36:1882–1889
55. Boerma EC, Ince C (2010) The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients. Intensive Care Med 36:2004–2018
56. Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM (2009) The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 37:1961–1966
57. Dubin A, Pozo MO, Casabella CA et al (2009) Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care 13:R92
58. Thooft A, Favory R, Salgado DR et al (2011) Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care 15:R222
59. Morelli A, Ertmer C, Rehberg S et al (2008) Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 12:R143
60. Morelli A, Lange M, Ertmer C et al (2008) Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: a crossover pilot study. Shock 29:446–451
61. Dubois MJ, De Backer D, Creteur J, Anane S, Vincent JL (2003) Effect of vasopressin on sublingual microcirculation in a patient with distributive shock. Intensive Care Med 29:1020–1023
62. Nygren A, Thoren A, Ricksten SE (2009) Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock. Acta Anaesthesiol Scand 53:581–588
63. Boerma EC, van der Voort PHJ, Ince C (2005) Sublingual microcirculatory flow is impaired by the vasopressin- analogue terlipressin in a patient with catecholamine-resistant septic shock. Acta Anaesthesiol Scand 49:1387–1390
64. Asfar P, Bracht H, Radermacher P (2008) Impact of vasopressin analogues on the gut mucosal microcirculation. Best Pract Res Clin Anaesthesiol 22:351–358
65. Morelli A, Donati A, Ertmer C et al (2011) Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock. Intensive Care Med 37:963–969
66. Morelli A, Donati A, Ertmer C et al (2011) Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock. Crit Care 15:R217
67. Qiu X, Huang Y, Xu J, Qiu H, Yang Y (2014) Effects of terlipressin on microcirculation of small bowel mesentery in rats with endotoxic shock. J Surg Res 188:503–509
68. De Backer D, Creteur J, Dubois MJ et al (2006) The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 34:403–408
69. Enrico C, Kanoore Edul VS et al (2012) Systemic and microcirculatory effects of dobutamine in patients with septic shock. J Crit Care 27:630–638
70. 2 extraction during septic shock. J Appl Physiol 122:1406–1417
71. Dubin A, Murias G, Sottile JP et al (2007) Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 33:485–494
72. Morelli A, Donati A, Ertmer C et al (2010) Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study. Crit Care 14:R232
73. Fuchs C, Ertmer C, Rehberg S (2016) Effects of vasodilators on haemodynamic coherence. Best Pract Res Clin Anaesthesiol 30:479–489
74. Webber J, MacDonald A (1993) Metabolic actions of catecholamines in man. Baillière’s Clin Endocrinol Metab 7:393–413
75. Van den Berghe G, de Zegher F (1996) Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24(9):1580–1590
76. Sharshar T, Annane D (2008) Endocrine effects of vasopressin in critically ill patients. Best Pract Res Clin Anesthesiol 22:265–273
77. Bermejo-Martin JF, Andaluz-Ojeda D, Almansa R et al (2016) Defining immunological dysfunction in sepsis: a requisite tool for precision medicine. J Infect 72(5):525–536
78. Parissis JT, Adamopoulos S, Antoniades C et al (2004) Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. Am J Cardiol 93(10):1309–1312
79. Russell JA, Fjell C, Hsu JL et al (2013) Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Resp Crit Care Med 188(3):356–364
80. Russell JA, Walley KR (2010) Vasopressin and its immune effects in septic shock. J Innate Immun 2(5):446–460
81. Gamper G, Havel C, Arrich J et al (2016) Vasopressors for hypotensive shock. Cochrane Database Syst Rev 2:CD003709
82. Gordon AC, Mason AJ, Thirunavukkarusu N et al (2016) Effect of early vasopressin vs norephinephrine on kidney failure patients with septic shock. The Vanish randomised clinical trial. JAMA 316(5):509–518
83. Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877–887
84. Russell JA, Walley KR, Gordon AC et al (2009) Interaction of vasopressin infusion, corticosteroid treatment and mortality of septic shock. Crit Care Med 37(3):811–818
85. De Backer D, Biston P, Devriendt J et al (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362:779–789
86. Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld G, Wunsch H (2017) Association Between US norepinephrine shortage and mortality among patients with septic shock. JAMA 317(14):1433–1442
87. Belletti A, Benedetto U, Biondi-Zoccai G et al (2017) The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials. J Crit Care 37:91–98
88. Mehaffey JH, Johnston LE, Hawkins RB et al (2017) Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival. Ann Thorac Surg 104:36–41
89. Elkayam U, Tasissa G, Binanay C et al (2007) Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J 153(1):98–104
90. Shah P, Cowger JA (2014) Cardiogenic shock. Crit Care Clin 30(3):391–412
91. Aranda JM Jr, Schofield RB, Pauly DF et al (2003) Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Am Heart J 145(2):324–329
92. Harris T, Davenport R, Mak M, Brohi K (2018) The evolving science of trauma resuscitation. Emerg Med Clin North Am 36(1):85–106
93. Cannon JW (2018) Hemorrhagic Shock. N Engl J Med 378(4):370–379
94. Rossaint R, Bouillon B, Cerny V et al (2016) The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 20:100
95. Bayram B, Hocaoglu N, Atilla R, Kalkan S et al (2012) Effects of terlipressin in a rat model of severe uncontrolled hemorrhage via liver injury. Am J Emerg Med 30(7):1176–1182
96. Cohn SM, McCarthy J, Stewart RM et al (2011) Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg 35(2):430–439
97. Westermann I, Dunser MW, Haas T et al (2007) Endogenous vasopressin and copeptin response in multiple trauma patients. Shock 28(6):644–649
98. Hylands M, Toma A, Beaudoin N et al (2017) Early vasopressor use following traumatic injury: a systematic review. BMJ Open 7(11):e017559
99. Plurad DS, Talving P, Lam L et al (2011) Early vasopressor use in critical injury is associated with mortality independent from volume status. J Trauma 71(3):565–570 [discussion 570–572]
100. Sperry JL, Minei JP, Frankel HL (2008) Early use of vasopressors after injury: caution before constriction. J Trauma 64(1):9–14
101. Ponikowski P, Voors AA, Anker SD et al (2016) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) Developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 37(27):2129–2200
102. Excellence NIfHaC (2016) Sepsis: recognition, assessment and early management. In: sepsis: recognition, Assessment and early management. London.
103. Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F (2008) Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 36(6):1701–1706
104. Hollenberg SM (2009) Inotrope and vasopressor therapy of septic shock. Crit Care Clin 25(4):781–802 [ix]
105. LeDoux D, Astiz ME, Carpati CM, Rackow EC (2000) Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 28:2729–2732
106. Bourgoin A, Leone M, Delmas A, Garnier F, Albanese J, Martin C (2005) Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33:780–786
107. Asfar P, Meziani F, Hamel JF et al (2014) High versus low blood-pressure targets in patients with septic shock. N Engl J Med 370:1583–1593
108. Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330(24):1717–1722
109. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA, Emergency Medicine Shock Research Network (EMShockNet) Investigators (2010) Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 303(8):739–746
110. Jansen TC, van Bommel J, Schoonderbeek FJ et al (2010) LACTATE study group: early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 182:752–761
111. Teboul JL, Saugel B, Cecconi M et al (2016) Less invasive hemodynamic monitoring in critically ill patients. Intensive Care Med 42:1350–1359
112. Cecconi M, De Backer D, Antonelli M et al (2014) Consensus on circulatory shock and hemodynamic monitoring. task force of the European society of intensive care medicine. Intensive Care Med 40:1795–1815
113. Merouani M, Guignard B, Vincent F et al (2008) Norepinephrine weaning in septic shock patients by closed loop control based on fuzzy logic. Crit Care 12:R155
114. Hammond DA, McCain K, Painter JT et al (2017) Discontinuation of vasopressin before norepinephrine in the recovery phase of septic shock. J Intensive Care Med 2017:885066617714209
115. Bissell BD, Magee C, Moran P, Bastin MLT, Flannery AH (2017) Hemodynamic instability secondary to vasopressin withdrawal in septic shock. J Intensive Care Med 2017:885066617716396
116. Annane D, Sébille V, Duboc D et al (1998) Incidence and prognosis of sustained arrhythmias in critically ill patients. Am J Respir Crit Care Med 178(1):20–25
117. Kido K, Guglin M (2017) Drug-induced takotsubo cardiomyopathy. J Cardiovasc Pharmacol Ther 22(6):552–563